BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)

  September 18, 2026

   · 

  5 min read
• 

  Neuropsychiatric disorders

  Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity

  As Xenon Pharmaceuticals announced that azetukalner has reached the FDA for focal seizures, the company also disclosed the emergence of psychosis adverse events in psychiatric trials of the drug, triggering a temporary pause.

  September 18, 2026

   · 

  4 min read

   · 

  Annalee Armstrong
• Press Releases

  MUSE Cells Now Available at Longevity Medical Institute®

  As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.

  September 18, 2026

   · 

  1 min read
• 

  IPO

  Electra lights up with $350M IPO for pivotal immune-disease drug development

  Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal development plans for its monoclonal antibody ipsoprubart.

  September 18, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• Press Releases

  Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

  Theralase® Provides Updates on its Phase II Bladder Cancer Clinical Study and Oncology Pipeline This Press Release adds omitted safety and prescribing information about Adstiladrin® (nadofaragene firadenovec-vncg)

  September 18, 2026

   · 

  12 min read
• Press Releases

  Evia Bio Closes Series A Financing to Accelerate Growth of DMSO-Free Cryopreservation Solutions

  September 18, 2026

   · 

  1 min read
• 

  China

  China plans to transform biotech sector into $522B powerhouse by 2030

  A new five-year biotech plan has been released by the Chinese government, revealing ambitious goals such as achieving five blockbuster medicines on the global markets in that time.

  September 18, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders’ Equity Compliance

  September 18, 2026

   · 

  9 min read
• Press Releases

  TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue

  Company reports US$522K in July sales, US$403K in August sales, and US$2.07M in sales for the first eight months of 2026, surpassing US$1.8M in total sales for 2025

  September 18, 2026

   · 

  7 min read